Korea Joongang Daily
Korea JoongAng Daily

Key executive convicted of defrauding JPMorgan Chase sentenced to over 5 years in prison

A top executive at a startup company that eased the process for college students applying for financial aid was sentenced Wednesday to over five years in prison for cheating JPMorgan Chase in a $175 million acquisition of the company four years ago.

2025-11-06

JPMorgan Chase unveils new 60-story headquarters, reshaping New York City's skyline

JPMorgan Chase unveiled its new 60-story headquarters to the public on Monday, one of the first major office buildings to be constructed after the Covid-19 pandemic and one that will remake the New York City skyline for decades.

2025-10-22

As AI agents reshape finance, success hinges on balancing innovation and security

AI agents are stepping up in the traditionally cautious world of finance, acting as digital co-workers and taking on more sophisticated tasks, from personalized customer service to fraud prevention.

2025-10-15

S. Korea's equity benchmark to reach 4,000 in next 12 months: JPMorgan

Korea's stock benchmark is expected to reach around 4,000 in the next 12 months, an analyst from JPMorgan Chase said on Monday.

2025-09-29

JP Morgan: Kospi to hit 5,000 ‘over a two year period’

U.S. investment bank JP Morgan Chase said the benchmark Kospi index could climb to 5,000 within two years and upgraded its view of Korean equities to overweight.

2025-07-13

Biotech companies share industry plans at J.P. Morgan Healthcare Conference

Thousands of biotech executives and investors from across the globe have flocked to San Francisco to attend the annual J.P. Morgan Healthcare Conference and look for potential deals, following a tough 2022 that saw patent cliffs and drought of M&A.

2023-01-10

Brokerages earn 23.6 billion won in short selling fees in H1: data

Brokerages in Korea raked in a combined 23.61 billion won ($16.5 million) in fees from handling stock short selling in the first half of this year, data showed Tuesday.

2022-09-27

Pharmaceutical companies update market, pitch products, at conference

Hanmi Pharmaceutical is expected to receive U.S. Food and Drug Administration (FDA) marketing approvals for two new drugs this year, CEO Kwon Se-chang said during the 40th annual J.P. Morgan HealthCare Conference.

2022-01-13